NDC 0006-4109 – Gardasil
Human Papillomavirus Type 6 L1 Capsid Protein Antigen 20 ug/.5mL; Human Papillomavirus Type 11 L1 Capsid Protein Antigen 40 ug/.5mL; Human Papillomavirus Type… · Injection, Suspension · Intramuscular
Product NDC0006-4109
Product details
- Brand name
- Gardasil
- Generic name
- Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant
- Labeler
- Merck Sharp & Dohme LLC
- Dosage form
- Injection, Suspension
- Route
- Intramuscular
- Marketing category
- BLA · BLA125126
- Marketed since
- June 8, 2006
- Listing expires
- December 31, 2026
- Pharmacologic class
- Inactivated Human Papillomavirus Vaccine; Inactivated Human Papillomavirus Vaccine; Inactivated Human Papillomavirus Vaccine; Inactivated Human Papillomavirus Vaccine
Active ingredients
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0006-4109-02 | 10 SYRINGE in 1 CARTON (0006-4109-02) / .5 mL in 1 SYRINGE (0006-4109-01) | Jun 8, 2006 |
| 0006-4109-09 | 6 SYRINGE in 1 CARTON (0006-4109-09) / .5 mL in 1 SYRINGE (0006-4109-01) | Jun 8, 2006 |
Other Gardasil products
- 0006-4045 Human Papillomavirus Type 6 L1 Capsid Protein Antigen 20 ug/.5mL;… · Injection, Suspension · Merck Sharp & Dohme LLC